Matt's Take Matthew Herper STAT Plus: By approving Biogen’s Alzheimer’s drug, the FDA is shifting its rules. That is a giant risk
Matt's Take Matthew Herper Having pandemic panic attacks about virus variants? National preparation is the cure
Matt's Take Matthew Herper Biden’s plan to end policy of keeping Covid vaccine doses in reserve is the first step in a difficult journey
Matt's Take Matthew Herper Antibody drugs seem to work. But the virus is moving faster than we can make them
Matt's Take Matthew Herper The lesson from Trump catching Covid-19: With this virus, there are no magic bullets
Matt's Take Matthew Herper Eager for a Covid vaccine, Trump now trusts drug companies he previously vilified
Matt's Take Matthew Herper People are dying from coronavirus because we’re not fast enough at clinical research
Matt's Take Matthew Herper The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable
Matt's Take Matthew Herper Coronavirus testing is starting to get better — but it has a long way to go
Matt's Take Matthew Herper The coronavirus exposes our health care system’s weaknesses. We can be stronger
Biotech Adam Feuerstein and Matthew Herper STAT Plus: STAT’s guide to the most important, beneficial drugs approved in the past decade
Matt's Take Matthew Herper The debate over America’s drug-pricing system is built on myths. It’s time to face reality
